International Clinical Trial: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828470) titled 'A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of KL0011034 Injection Administered by Continuous Infusion in Healthy Adult Subjects' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.

Condition: Healthy Volunteers

Intervention: Drug: KL0011034 injection

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 13, 2026

Target ...